Windward Bio
Latest round
- Series B
Last raised
- May 2026
Total raised
- $365M
Investors
- 13
About Windward Bio
Based in Basel, Switzerland, Windward Bio AG specializes in creating therapeutic solutions for severe immunological conditions. The company was founded by its CEO, Luca Santarelli. Windward Bio focuses on the development of advanced therapeutic solutions aimed at improving outcomes for individuals with severe immunological diseases, particularly severe respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The company's primary product is WIN378, a novel recombinant fully human monoclonal antibody designed to selectively bind to the thymic stromal lymphopoietin (TSLP) ligand, a cytokine linked to a range of inflammatory diseases. By inhibiting the TSLP ligand, WIN378 aims to reduce the inflammatory responses associated with these conditions, thereby potentially offering benefits to patients. Additionally, the firm is developing long-acting bispecific antibody programs tailored to treat various immunological disorders. The company generates revenue through partnerships with healthcare providers and pharmaceutical companies, potentially employing a business-to-business (B2B) transaction structure.
Who invested in Windward Bio
13 investors across 2 rounds
See all investors in Windward Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Windward Bio
Who invested in Windward Bio?
Windward Bio has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Windward Bio raised?
Windward Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Windward Bio last raise money?
Windward Bio's most recent round on record is a Series B, in May 2026.
What does Windward Bio do?
Based in Basel, Switzerland, Windward Bio AG specializes in creating therapeutic solutions for severe immunological conditions.
Where is Windward Bio headquartered?
Windward Bio is headquartered in Basel, Switzerland.
Which VCs invest in companies like Windward Bio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Windward Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Windward Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.